BioSpace News Archive

Seelos Therapeutics, Inc. today announced that it will participate in two upcoming psychedelic conferences.

INOVIO today announced that Jacqueline Shea , Ph.D., President and CEO, will present at the H.C. Wainwright 24th Annual Global Conference.

Indica Labs The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics ( iCAIRD ), announced today an agreement to collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases.

DiamiR today announced the expansion of its management team by the appointment of Fred Knechtel as Chief Financial Officer (CFO), effective immediately.

Cybin Inc. is pleased to announce that the first two participants have been dosed in its Phase 1/2a trial evaluating CYB003 for the treatment of major depressive disorder.

S2 Genomics, Inc., today announced that it has entered into a distribution agreement with Eisenberg for the promotion, sales, and support of S2’s Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in Israel.

Bayer will present key scientific research in oncology at the upcoming ESMO Congress 2022 from September 9-13, 2022.

Parse Biosciences announced today a significant performance update of its chemistry for the Evercode™ Whole Transcriptome products.

With the World Health Organization declaring the monkeypox virus (MPXV) a Public Health Emergency of International Concern, and more than 47,000 total cases across 99 countries reported to date and growing, Integrated DNA Technologies (IDT) is supporting researchers conducting monkeypox surveillance with a new next generation sequencing (NGS) solution.

Evolus, Inc. has named Sandra Beaver as its Chief Financial Officer, effective September 5, 2022.